Sunday, January 01, 2012

To Prevent Abuse, Create a Cartel?

Anonyman sends this remarkable article. Excerpt:

While the Food and Drug Administration monitors the safety and supply of the drugs, which are sold both as generics and under brand names like Ritalin and Adderall, the Drug Enforcement Administration sets manufacturing quotas that are designed to control supplies and thwart abuse. Every year, the D.E.A. accepts applications from manufacturers to make the drugs, analyzes how much was sold the previous year and then allots portions of the expected demand to various companies.

So, to "prevent abuse," what the gubmint is doing is protecting cartel profits, even in a GENERIC drug. And of course if there is a shortage, that means that rich people who want to abuse the drug will still get it, but poor people who want to use the drug legally can just go screw themselves.

I would like to propose that before you work for the US federal government you have to pass a high-school level econ class. Is that too much to ask?

4 comments:

Anonymous said...

Careful what you wish for. A high school level econ class would be taught by government employees with a cirriculum determined by poloticians.

Tom said...

I fear your "high-school level econ class" would be designed by the likes of Paul Krugman.

...OR you could let ME design it. Then the entire Gummit would some comatose patients, Quakers, and anarchists. Even Ron Paul would fail the "are you a nanny" test.

Umm. After typing the above I see capcha: unkingma

Brad Hutchings said...

You obviously haven't seen today's news that the EEOC is trying to create a cartel for underachievers. So, no, you can't have that requirement.

Dirty Davey said...

The cartel to "prevent abuse" is of course part of the "War on Drugs"--or as LGM calls it the "War on (Some Classes of People Who Use Some) Drugs".

You should know by now that drugs are SO EVIL and that the war on drugs is SO IMPORTANT that not only economic principles but even basic rationality can be ignored in setting drug policies.